CX3CL1 and anaplastic astrocytoma: In another study, the expression of CX3CL1 was inversely correlated with patient overall survival with the uppermost scores of CX3CL1 expression in grades 3–4 tumors: oligodendrogliomas, anaplastic astrocytomas, and GBM [70].